{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T04:02:42Z","timestamp":1648699362581},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2008,8,15]],"date-time":"2008-08-15T00:00:00Z","timestamp":1218758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"DOI":"10.1007\/s00393-008-0346-x","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T14:03:56Z","timestamp":1218636236000},"source":"Crossref","is-referenced-by-count":0,"title":["Interdisziplin\u00e4re Ber\u00fchrungspunkte zwischen Rheumatologie und Pneumologie"],"prefix":"10.1007","author":[{"given":"J.","family":"Hermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Scheidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,15]]},"reference":[{"key":"346_CR1","doi-asserted-by":"crossref","unstructured":"Ferri C, Valentini G, Cozzi F et al. (2002) Systemic sclerosis: demographic, clinical and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81: 139\u2013153","DOI":"10.1097\/00005792-200203000-00004"},{"key":"346_CR2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00393-006-0065-0","volume":"65","author":"Genth","year":"2006","unstructured":"Genth E, Krieg T (2006) Systemic sclerosis - diagnosis and classification. Z Rheumatol 65: 268\u2013274","journal-title":"Z Rheumatol"},{"key":"346_CR3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/ard.60.6.585","volume":"60","author":"Della","year":"2001","unstructured":"Della Rossa A, Valentini G, Bombardieri S et al. (2001) European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 60: 585\u2013591","journal-title":"Ann Rheum Dis"},{"key":"346_CR4","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","volume":"52","author":"Hachulla","year":"2005","unstructured":"Hachulla E, Gressin V, Guillevin L et al. (2005) Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52: 3792\u20133800","journal-title":"Arthritis Rheum"},{"key":"346_CR5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","volume":"62","author":"Mukerjee","year":"2003","unstructured":"Mukerjee D, St George D, Coleiro B et al. (2003) Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 62: 1088\u20131093","journal-title":"Ann Rheum Dis"},{"key":"346_CR6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/rheumatology\/31.9.609","volume":"31","author":"Langevitz","year":"1992","unstructured":"Langevitz P, Buskila D, Gladman DD et al. (1992) HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome. Br J Rheumatol 31: 609\u2013613","journal-title":"Br J Rheumatol"},{"key":"346_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","volume":"48","author":"Steen","year":"2003","unstructured":"Steen V, Medsger TA jr (2003) Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 48: 516\u2013522","journal-title":"Arthritis Rheum"},{"key":"346_CR8","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/art.21225","volume":"52","author":"Chatterjee","year":"2005","unstructured":"Chatterjee S, Dombi GW, Severson RK et al. (2005) Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 52: 2415\u20132424","journal-title":"Arthritis Rheum"},{"key":"346_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","volume":"67","author":"Czirjak","year":"2008","unstructured":"Czirjak L, Kumanovics G, Varju C et al. (2008) Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 67: 59\u201363","journal-title":"Ann Rheum Dis"},{"key":"346_CR10","doi-asserted-by":"crossref","unstructured":"Mukerjee D, St George D, Knight C et al. (2004) Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 43: 461\u2013466","DOI":"10.1093\/rheumatology\/keh067"},{"key":"346_CR11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1378\/chest.110.6.1520","volume":"110","author":"Schwaiblmair","year":"1996","unstructured":"Schwaiblmair M, Behr J, Fruhmann G (1996) Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 110: 1520\u20131525","journal-title":"Chest"},{"key":"346_CR12","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","volume":"25","author":"Galie","year":"2004","unstructured":"Galie N, Torbicki A, Barst R et al. (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the european society of cardiology. Eur Heart J 25: 2243\u20132278","journal-title":"Eur Heart J"},{"key":"346_CR13","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/art.22204","volume":"54","author":"Hoyles","year":"2006","unstructured":"Hoyles RK, Ellis RW, Wellsbury J et al. (2006) A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54: 3962\u20133970","journal-title":"Arthritis Rheum"},{"key":"346_CR14","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ et al. (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354: 2655\u20132666","journal-title":"N Engl J Med"},{"key":"346_CR15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00393-006-0101-0","volume":"65","author":"Tomiak","year":"2006","unstructured":"Tomiak C, Dorner T (2006) Sjogren\u2019s syndrome. Current aspects from a rheumatological point of view. Z Rheumatol 65: 505\u2013517 quiz 518\u2013509","journal-title":"Z Rheumatol"},{"key":"346_CR16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al. (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"346_CR17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0272-5231(05)70110-6","volume":"19","author":"Cain","year":"1998","unstructured":"Cain HC, Noble PW, Matthay RA (1998) Pulmonary manifestations of Sjogren\u2019s syndrome. Clin Chest Med 19: 687\u2013699","journal-title":"Clin Chest Med"},{"key":"346_CR18","first-page":"831","volume":"20","author":"Gardiner","year":"1993","unstructured":"Gardiner P, Ward C, Allison A et al. (1993) Pleuropulmonary abnormalities in primary Sjogren\u2019s syndrome. J Rheumatol 20: 831\u2013837","journal-title":"J Rheumatol"},{"key":"346_CR19","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00005382-200110000-00009","volume":"16","author":"Uffmann","year":"2001","unstructured":"Uffmann M, Kiener HP, Bankier AA et al. (2001) Lung manifestation in asymptomatic patients with primary Sjogren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging 16: 282\u2013289","journal-title":"J Thorac Imaging"},{"key":"346_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.58.1.61","volume":"58","author":"Papiris","year":"1999","unstructured":"Papiris SA, Maniati M, Constantopoulos SH et al. (1999) Lung involvement in primary Sjogren\u2019s syndrome is mainly related to the small airway disease. Ann Rheum Dis 58: 61\u201364","journal-title":"Ann Rheum Dis"},{"key":"346_CR21","doi-asserted-by":"crossref","unstructured":"Launay D, Hachulla E, Hatron PY et al. (2007) Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 86: 299\u2013315","DOI":"10.1097\/MD.0b013e3181579781"},{"key":"346_CR22","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"Kassan","year":"2004","unstructured":"Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 164: 1275\u20131284","journal-title":"Arch Intern Med"},{"key":"346_CR23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00002281-199002050-00002","volume":"2","author":"Youinou","year":"1990","unstructured":"Youinou P, Moutsopoulos HM, Pennec YL (1990) Clinical features of Sjogren\u2019s syndrome. Curr Opin Rheumatol 2: 687\u2013693","journal-title":"Curr Opin Rheumatol"},{"key":"346_CR24","first-page":"845","volume":"35","author":"Locht","year":"2008","unstructured":"Locht H, Pelck R, Manthorpe R (2008) Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjogren\u2019s syndrome. J Rheumatol 35: 845\u2013849","journal-title":"J Rheumatol"},{"key":"346_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10067-005-0059-3","volume":"25","author":"Nardi","year":"2006","unstructured":"Nardi N, Brito-Zeron P, Ramos-Casals M et al. (2006) Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjogren\u2019s syndrome: prevalence and clinical significance in 335 patients. Clin Rheumatol 25: 341\u2013346","journal-title":"Clin Rheumatol"},{"key":"346_CR26","first-page":"907","volume":"33","author":"S\u00e1nchez-Guerrero","year":"2006","unstructured":"S\u00e1nchez-Guerrero J, P\u00e9rez-Dosal MR, Celis-Aguilar E et al. (2006) Validity of screening tests for Sj\u00f6gren\u2019s syndrome in ambulatory patients with chronic diseases. J Rheumatol 33: 907\u2013911","journal-title":"J Rheumatol"},{"key":"346_CR27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.60.12.1110","volume":"60","author":"Kalk","year":"2001","unstructured":"Kalk WW, Vissink A, Spijkervet FK et al. (2001) Sialometry and sialochemistry: diagnostic tools for Sjogren\u2019s syndrome. Ann Rheum Dis 60: 1110\u20131116","journal-title":"Ann Rheum Dis"},{"key":"346_CR28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10067-007-0586-1","volume":"26","author":"Henriksen","year":"2007","unstructured":"Henriksen AM, Nossent HC (2007) Quantitative salivary gland scintigraphy can distinguish patients with primary Sjogren\u2019s syndrome during the evaluation of sicca symptoms. Clin Rheumatol 26: 1837\u20131841","journal-title":"Clin Rheumatol"},{"key":"346_CR29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.23579","volume":"59","author":"Caporali","year":"2008","unstructured":"Caporali R, Bonacci E, Epis O et al. (2008) Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum 59: 714\u2013720","journal-title":"Arthritis Rheum"},{"key":"346_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0049-0172(03)00083-0","volume":"33","author":"Abril","year":"2003","unstructured":"Abril A, Calamia KT, Cohen MD (2003) The churg strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum 33: 106\u2013114","journal-title":"Semin Arthritis Rheum"},{"key":"346_CR31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/BOR.0b013e3280119854","volume":"19","author":"Pagnoux","year":"2007","unstructured":"Pagnoux C, Guilpain P, Guillevin L (2007) Churg-Strauss syndrome. Curr Opin Rheumatol 19: 25\u201332","journal-title":"Curr Opin Rheumatol"},{"key":"346_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187\u2013192","journal-title":"Arthritis Rheum"},{"key":"346_CR33","doi-asserted-by":"crossref","unstructured":"Lanham JG, Elkon KB, Pusey CD et al. (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 63: 65\u201381","DOI":"10.1097\/00005792-198403000-00001"},{"key":"346_CR34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1148\/radiology.216.3.r00se01773","volume":"216","author":"Johkoh","year":"2000","unstructured":"Johkoh T, Muller NL, Akira M et al. (2000) Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 216: 773\u2013780","journal-title":"Radiology"},{"key":"346_CR35","doi-asserted-by":"crossref","unstructured":"Jederlinic PJ, Sicilian L, Gaensler EA (1988) Chronic eosinophilic pneumonia. A report of 19 cases and a review of the literature. Medicine (Baltimore) 67: 154\u2013162","DOI":"10.1097\/00005792-198805000-00002"},{"key":"346_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/rheumatology\/keh617","volume":"32","author":"Keystone","year":"2005","unstructured":"Keystone EC (2005) Safety of Biologic Therapies \u2013 An Update. J Rheumatol 32: 8\u201312","journal-title":"J Rheumatol"},{"key":"346_CR37","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","volume":"52","author":"Askling","year":"2005","unstructured":"Askling J, Fored CM, Brandt L et al. (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52: 1986\u20131992","journal-title":"Arthritis Rheum"},{"key":"346_CR38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00393-005-0018-z","volume":"65","author":"Gaemperli","year":"2006","unstructured":"Gaemperli A, Hauser T, Speck R (2006) Risk of infection during treatment with tumor necrosis factor-alpha inhibitors. Z Rheumatol 65: 24\u201328","journal-title":"Z Rheumatol"},{"key":"346_CR39","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/424455","volume":"39","author":"Wallis","year":"2004","unstructured":"Wallis RS, Broder M, Wong J et al. (2004) Granulomatous infections due to tumor necrosis factor blockade: correction. Clin Infect Dis 39: 1254\u20131255","journal-title":"Clin Infect Dis"},{"key":"346_CR40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","volume":"38","author":"Wallis","year":"2004","unstructured":"Wallis RS, Broder MS, Wong JY et al. (2004) Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38: 1261\u20131265","journal-title":"Clin Infect Dis"},{"key":"346_CR41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/430914","volume":"41","author":"Wallis","year":"2005","unstructured":"Wallis RS (2005) Reconsidering adjuvant immunotherapy for tuberculosis. Clin Infect Dis 41: 201\u2013208","journal-title":"Clin Infect Dis"},{"key":"346_CR42","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1086\/429996","volume":"41","author":"Wallis","year":"2005","unstructured":"Wallis RS, Broder M, Wong J et al. (2005) Reactivation of latent granulomatous infections by infliximab. Clin Infect Dis 41 (Suppl 3): S194\u2013S198","journal-title":"Clin Infect Dis"},{"key":"346_CR43","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098\u20131104","journal-title":"N Engl J Med"},{"key":"346_CR44","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340\u2013354","journal-title":"Ann Intern Med"},{"key":"346_CR45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM jr (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761\u2013776","journal-title":"Lancet Infect Dis"},{"key":"346_CR46","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/jama.1986.03370120057023","volume":"255","author":"Snider","year":"1986","unstructured":"Snider DE jr, Caras GJ, Koplan JP (1986) Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA 255: 1579\u20131583","journal-title":"JAMA"},{"key":"346_CR47","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","author":"American","year":"2000","unstructured":"American Thoracic Society (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 161: S221\u2013S247","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0346-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0346-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0346-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:35:56Z","timestamp":1559061356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0346-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,15]]},"references-count":47,"alternative-id":["346"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0346-x","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,15]]}}}